| Reversal of experimental pulmonary hypertension by PDGF inhibition RT Schermuly, E Dony, HA Ghofrani, S Pullamsetti, R Savai, M Roth, ... The Journal of clinical investigation 115 (10), 2811-2821, 2005 | 1301 | 2005 |
| Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension R Savai, SS Pullamsetti, J Kolbe, E Bieniek, R Voswinckel, L Fink, ... American journal of respiratory and critical care medicine 186 (9), 897-908, 2012 | 421 | 2012 |
| Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension RT Schermuly, JP Stasch, SS Pullamsetti, R Middendorff, D Müller, ... European Respiratory Journal 32 (4), 881-891, 2008 | 305 | 2008 |
| Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension R Savai, HM Al-Tamari, D Sedding, B Kojonazarov, C Muecke, R Teske, ... Nature medicine 20 (11), 1289-1300, 2014 | 291 | 2014 |
| Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension SS Pullamsetti, C Doebele, A Fischer, R Savai, B Kojonazarov, BK Dahal, ... American journal of respiratory and critical care medicine 185 (4), 409-419, 2012 | 264 | 2012 |
| Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer A Schmall, HM Al-Tamari, S Herold, M Kampschulte, A Weigert, ... American journal of respiratory and critical care medicine 191 (4), 437-447, 2015 | 261 | 2015 |
| Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension S Pullamsetti, L Kiss, HA Ghofrani, R Voswinckel, P Haredza, W Klepetko, ... The FASEB journal 19 (9), 1175-1177, 2005 | 244 | 2005 |
| MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts D Wang, H Zhang, M Li, MG Frid, AR Flockton, BA McKeon, ME Yeager, ... Circulation research 114 (1), 67-78, 2014 | 237 | 2014 |
| Long noncoding RNA MANTIS facilitates endothelial angiogenic function MS Leisegang, C Fork, I Josipovic, FM Richter, J Preussner, J Hu, ... Circulation 136 (1), 65-79, 2017 | 236 | 2017 |
| Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension KC El Kasmi, SC Pugliese, SR Riddle, JM Poth, AL Anderson, MG Frid, ... The Journal of Immunology 193 (2), 597-609, 2014 | 222 | 2014 |
| Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy RT Schermuly, SS Pullamsetti, G Kwapiszewska, R Dumitrascu, X Tian, ... Circulation 115 (17), 2331-2339, 2007 | 203 | 2007 |
| Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling M Klein, RT Schermuly, P Ellinghaus, H Milting, B Riedl, S Nikolova, ... Circulation 118 (20), 2081-2090, 2008 | 185 | 2008 |
| Matrix metalloproteinases and their inhibitors in pulmonary hypertension P Chelladurai, W Seeger, SS Pullamsetti European Respiratory Journal 40 (3), 766-782, 2012 | 181 | 2012 |
| Targeting cancer with phosphodiesterase inhibitors R Savai, SS Pullamsetti, GA Banat, N Weissmann, HA Ghofrani, ... Expert opinion on investigational drugs 19 (1), 117-131, 2010 | 178 | 2010 |
| Immune and inflammatory cell composition of human lung cancer stroma GA Banat, A Tretyn, SS Pullamsetti, J Wilhelm, A Weigert, C Olesch, ... PLOS one 10 (9), e0139073, 2015 | 169 | 2015 |
| Role of epidermal growth factor inhibition in experimental pulmonary hypertension BK Dahal, T Cornitescu, A Tretyn, SS Pullamsetti, D Kosanovic, ... American journal of respiratory and critical care medicine 181 (2), 158-167, 2010 | 169 | 2010 |
| Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF SS Pullamsetti, GA Banat, A Schmall, M Szibor, D Pomagruk, J Hänze, ... Oncogene 32 (9), 1121-1134, 2013 | 162 | 2013 |
| Increased smooth muscle cell expression of caveolin‐1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension HH Patel, S Zhang, F Murray, RYS Suda, BP Head, U Yokoyama, ... The FASEB Journal 21 (11), 2970-2979, 2007 | 157 | 2007 |
| Role of Src tyrosine kinases in experimental pulmonary hypertension SS Pullamsetti, EM Berghausen, S Dabral, A Tretyn, E Butrous, R Savai, ... Arteriosclerosis, thrombosis, and vascular biology 32 (6), 1354-1365, 2012 | 144 | 2012 |
| Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C … M Li, S Riddle, H Zhang, A D’Alessandro, A Flockton, NJ Serkova, ... Circulation 134 (15), 1105-1121, 2016 | 139 | 2016 |
